CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $374,000 | -10.5% | 19,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $418,000 | +11.2% | 19,000 | +20.3% | 0.01% | 0.0% |
| Q1 2021 | $376,000 | -9.0% | 15,800 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $413,000 | +36.3% | 15,800 | -9.2% | 0.01% | +28.6% |
| Q3 2020 | $303,000 | -43.4% | 17,400 | -61.8% | 0.01% | 0.0% |
| Q1 2019 | $535,000 | -34.8% | 45,600 | -25.7% | 0.01% | -36.4% |
| Q4 2018 | $820,000 | +88.5% | 61,400 | +98.1% | 0.01% | +175.0% |
| Q3 2018 | $435,000 | -10.7% | 31,000 | 0.0% | 0.00% | -20.0% |
| Q2 2018 | $487,000 | -4.5% | 31,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $510,000 | -22.3% | 31,000 | -14.6% | 0.01% | -28.6% |
| Q4 2017 | $656,000 | -10.1% | 36,300 | -4.0% | 0.01% | -12.5% |
| Q3 2017 | $730,000 | +19.7% | 37,800 | -26.9% | 0.01% | +14.3% |
| Q2 2017 | $610,000 | +7.6% | 51,700 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $567,000 | +51.2% | 51,700 | 0.0% | 0.01% | +40.0% |
| Q4 2016 | $375,000 | – | 51,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |